Eli Lilly and Company (India), in collaboration with the Association of Physicians of India (API), has launched ‘API – Obesity Gurukul’, a Continuing Medical Education (CME) program aimed at helping physicians better manage obesity, which is becoming one of India’s major public health challenges.

Taking inspiration from the traditional Indian Gurukul system, the program will offer a structured and immersive learning experience for over 20,000 healthcare professionals across more than 10 cities. Through a combination of in-person educational sessions conducted by API state chapters and interactive online modules, the initiative will provide practical insights into the understanding of obesity, its causes, and its management.

“Obesity is a complex, chronic condition that requires more than just treatment—it demands continuous medical education, empathy, and coordinated action across the healthcare system,” said Dr. Manish Mistry, Senior Medical Director, Eli Lilly and Company (India). “Our partnership with the Association of Physicians of India (API) on the Obesity Gurukul program reflects our effort to advance clinical knowledge and improve how obesity is understood and managed in India. By equipping physicians with the latest scientific information and best practices, we aim to strengthen the quality of care and support better outcomes for people living with obesity.”

Commenting on the partnership, Dr. Jyotimoy Pal, President of API, said, “Obesity is no longer just a lifestyle issue—it is a disease with significant clinical, psychological, and economic impact. The Obesity Gurukul program is an important step toward helping physicians recognize and treat obesity as a chronic condition.”

In India, close to 100 million people are living with obesity, with an adult prevalence rate of approximately 6.5% in 2023. People with obesity need the same level of medical attention as those living with other chronic diseases, including access to efficient and evidence-based long-term care.